Quantbot Technologies LP Allakos Inc. Transaction History

Quantbot Technologies LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$1.02 - $3.23 $7,344 - $23,256	-7,200 Reduced 31.3%	15,800 $19,000
Q4 2023 Feb 14, 2024	BUY	$1.72 - $3.18 $24,768 - $45,792	14,400 Added 167.44%	23,000 $62,000
Q3 2023 Nov 07, 2023	BUY	$2.13 - $5.55 $4,260 - $11,100	2,000 Added 30.3%	8,600 $19,000
Q2 2023 Aug 08, 2023	BUY	$3.6 - $5.25 $10,440 - $15,225	2,900 Added 78.38%	6,600 $28,000
Q1 2023 May 12, 2023	BUY	$4.3 - $8.27 $15,910 - $30,599	3,700 New	3,700 $16,000
Q3 2022 Nov 07, 2022	BUY	$3.02 - $6.12 $60,173 - $121,941	19,925 Added 124.54%	35,924 $219,000
Q2 2022 Aug 09, 2022	SELL	$2.6 - $6.14 $2,607 - $6,158	-1,003 Reduced 5.9%	15,999 $50,000
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $86,370 - $166,789	17,002 New	17,002 $96,000
Q4 2021 Feb 11, 2022	SELL	$8.55 - $111.89 $3,471 - $45,427	-406 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$76.53 - $110.43 $320,507 - $462,480	-4,188 Reduced 91.16%	406 $42,000
Q2 2021 Aug 12, 2021	BUY	$85.37 - $114.1 $363,505 - $485,837	4,258 Added 1267.26%	4,594 $392,000
Q1 2021 May 14, 2021	BUY	$109.73 - $153.66 $658 - $921	6 Added 1.82%	336 $38,000
Q4 2020 Feb 12, 2021	BUY	$79.58 - $152.45 $26,261 - $50,308	330 New	330 $46,000
Q3 2019 Nov 12, 2019	SELL	$31.0 - $89.73 $27,900 - $80,757	-900 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$36.0 - $44.73 $32,400 - $40,257	900 New	900 $38,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.